|Day Low/High||52.59 / 53.17|
|52 Wk Low/High||51.72 / 82.15|
Jim shares his thoughts on the U.S-China trade tensions, provides his view on what stocks to buy and what stocks to avoid in Thursday's market selloff, and more!
Our preference is to make smaller, incremental buys as the market comes in.
A look at the charts and indicators of three big names in the sector .
Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.
Uncertainty over the trade war's effects on earnings make this market really hard on investors, says Jim Cramer.
These managed care stocks can withstand China, politics and a slowdown in the economy.
CSCO shares are roaring higher in today's session following last night's terrific earnings release.
More than 1,400 products across 11 categories complete testing to verify labeled ingredients
Tuesday's rise disappointed, but any downside from here should bring on negative sentiment while we’re oversold, which should give us a real rally.
Services firms are less exposed to trade policy, say analysts at Goldman Sachs.
Our cash position has given us the opportunity to be flexible here and pick up stocks in good companies that recently reported strong earnings.
New safes for controlled substances anticipated to help reduce robbery incidents
Jim Cramer's worried the market could reel from the tariff increases and a disappointing Uber IPO. He says investors need to brace for the possibilities.
Jim Cramer takes a closer look at Starbucks, DexCom, HealthEquity, Turning Point Brands, Tilray, CVS Health, Timken and more.
Several headwinds are still holding back analysts from being more bullish on the stock.
32 Project Health events will help address access, affordability and quality care
RMPIA outperformed once gain during April.
Dow closes down about 162 points after central bank leaves fed-funds rate in a 2.25%-2.5% range.
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
CVS Health posts stronger-than-expected first-quarter earnings and boosts the mid-point of its full-year profit forecast as the healthcare benefits manager's $69 billion purchase of Aetna begins to influence its bottom line.
CVS' earnings rally could be the start of a much bigger move.
As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.
Jim discusses earnings from Apple, CVS, and Amgen and speaks to the up-and-down pattern he has seen this earnings season.
Curious about what Jim Cramer thinks about the CVS quarter? Here's what Jim Cramer thinks about the earnings.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.